Selected article for: "corona virus and high quality"

Author: Liu, Ming; Gao, Ya; Yuan, Yuan; Yang, Kelu; Shi, Shuzhen; Zhang, Junhua; Tian, Jinhui
Title: Efficacy and Safety of Integrated Traditional Chinese and Western Medicine for Corona Virus Disease 2019 (COVID-19): a systematic review and meta-analysis
  • Cord-id: rteysj8j
  • Document date: 2020_5_11
  • ID: rteysj8j
    Snippet: COVID-19 has now spread to all parts of the world and almost all countries are battling against it. This study aimed to assess the efficacy and safety of Integrated Traditional Chinese and Western Medicine (Hereinafter referred to as “Integrated Medicine”) to corona virus disease 2019 (COVID-19). We searched six major Chinese and English databases to identify randomized controlled trials (RCTs) and case-control studies (CCSs) of Integrated Medicine on COVID-19. Two reviewers independently sc
    Document: COVID-19 has now spread to all parts of the world and almost all countries are battling against it. This study aimed to assess the efficacy and safety of Integrated Traditional Chinese and Western Medicine (Hereinafter referred to as “Integrated Medicine”) to corona virus disease 2019 (COVID-19). We searched six major Chinese and English databases to identify randomized controlled trials (RCTs) and case-control studies (CCSs) of Integrated Medicine on COVID-19. Two reviewers independently screened, identified studies, and extracted data. Cochrane Risk of Bias tool and the Newcastle-Ottawa Scale were used to assess the quality of included RCTs and CCSs, respectively. Stata (version 13.0; StataCorp) was used to perform meta-analyses using the random-effects model. Risk ratio (RR) was used for dichotomous data while the weighted mean difference (WMD) was adopted for continuous variables as effect size, respectively, both of which were demonstrated in effect size and 95% confidence intervals. A total of 11 studies were included. Four were RCTs and seven were CCSs. The samples of including studies ranged from 18 to 100 (total 982). The traditional Chinese medicine included Chinese medicine compound drugs (QingFei TouXie FuZhengFang) and Chinese patent medicine (such as Shufeng Jiedu Capsule, Lianhua Qingwen granules). Compared with the control group, the overall response rate [RR = 1.230, 95%CI (1.113, 1.359), P = 0.000], cure rate [RR = 1.604, 95%CI (1.181, 2.177), P = 0.002], severity illness rate [RR = 0.350, 95%CI (0.154, 0.792), P = 0.012], and hospital stay [WMD = -1.991, 95%CI (-3.278, -0.703), P = 0.002] of the intervention group were better. In addition, Integrated Medicine can improve the disappearance rate of fever, cough, expectoration, fatigue, chest tightness and anorexia and reduce patients’ fever, and fatigue time (P < 0.05). This review found that Integrated Medicine had better effects and fewer adverse drug reactions for COVID-19. More high-quality RCTs will be needed in the future.

    Search related documents:
    Co phrase search for related documents
    • adjuvant therapy and low number: 1
    • adjuvant therapy and low quality: 1, 2, 3, 4, 5
    • liver damage and long period: 1, 2
    • liver damage and low number: 1, 2
    • long period and low number: 1, 2, 3, 4, 5, 6, 7, 8
    • long period and low quality: 1, 2